Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

FDA clears AI-powered cardiac imaging platform
The Tempus Pixel platform was designed to assist clinicians with the evaluation of cardiac MR images.
Key trends in nuclear cardiology take center stage at ASNC 2025
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
Open-source AI model delivers accurate echocardiography assessments
The algorithm, trained on more than 150,000 TTE studies, can calculate 18 different measurements regularly used in echocardiography
ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging
Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said.
Cardiologist Carlos Collet takes new leadership role with CRF
Collet, known globally for his dedication to innovation, is the organization's new director of cardiovascular imaging, physiology and translational therapeutics.

American Society of Echocardiography unveils new guidelines for comprehensive TTE

The American Society of Echocardiography has released new guidelines for performing a comprehensive transthoracic echocardiography (TTE) examination. The recommendations, which were endorsed by 22 other cardiology/echocardiography societies from around the world, were published in the January edition of the Journal of the American Society of Echocardiography.

Plaque characteristics boost predictive power of CTA risk scoring

A CT angiography (CTA)-derived score that also incorporated the extent, location and composition of coronary plaque outperformed a model that focused only on the severity of stenosis, researchers reported Jan. 16 in JACC: Cardiovascular Imaging.

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

Gantry breakthrough on industry-leading Azurion platform opens up new imaging and patient positioning opportunities to enhance care

The Cephea transcatheter mitral valve in development has been acquired by Medtronic.

Abbott acquires another TMVR device through purchase of Cephea

Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral valve replacement (TMVR) device, the Chicago-area healthcare giant announced Jan. 16.

FDA clears 1st imaging platform to select stroke patients for clot removal

The RAPID neuroimaging platform has been cleared by the FDA to use in selecting stroke patients for endovascular thrombectomy. It becomes the first imaging platform to receive such clearance for clot removal procedure, reported the creator of the technology, iSchemaView.

RAPID imaging platform cleared to select stroke patients for thrombectomy

The RAPID neuroimaging platform can now be used in the U.S. to select stroke patients who are likely to benefit from endovascular thrombectomy. It is the first imaging platform to be cleared by the FDA as a patient selection tool for this clot removal procedure, according to iSchemaView, which developed the technology.

RFPI receives FDA clearance to market iCertainty blood flow imaging device

GREENVILLE, N.C. — RFPi Inc. has received 510(k) clearance from the U.S. Food and Drug Administration to begin marketing for use by surgeons in open surgery its iCertainty™ blood flow and perfusion imaging medical device.

ACC releases new Appropriate Use Criteria for multimodality imaging of nonvalvular heart disease

The American College of Cardiology (ACC) and several other partnering societies, including the American Heart Association and American Society of Nuclear Cardiology, released on Monday, Jan. 7 its 2019 Appropriate Use Criteria (AUC) for multimodality imaging of nonvalvular heart disease.

Cardiac Imaging

FDA clears AI-powered cardiac imaging platform

Key trends in nuclear cardiology take center stage at ASNC 2025

Open-source AI model delivers accurate echocardiography assessments

ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging

Cardiologist Carlos Collet takes new leadership role with CRF